awaiting safety review
In contrast, the data on organic contaminants such as pharmaceutical residues or PFAS are still incomplete and do not yet allow for a comparably comprehensive assessment across all product groups.
In contrast, the data on organic contaminants such as pharmaceutical residues or PFAS are still incomplete and do not yet allow for a comparably comprehensive assessment across all product groups.